Review



cd34 percp cy5 5  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    Novus Biologicals cd34 percp cy5 5
    Cd34 Percp Cy5 5, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+percp+cy5+5/pmc08102597-209-22-23?v=Novus+Biologicals
    Average 91 stars, based on 1 article reviews
    cd34 percp cy5 5 - by Bioz Stars, 2026-07
    91/100 stars

    Images



    Similar Products

    cd309 percp cy5 5 cd31 fitc cd34 apc  (Revvity)
    98
    Revvity cd309 percp cy5 5 cd31 fitc cd34 apc
    Cd309 Percp Cy5 5 Cd31 Fitc Cd34 Apc, supplied by Revvity, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+percp+cy5+5/pmc10150485-73-10-18?v=Revvity
    Average 98 stars, based on 1 article reviews
    cd309 percp cy5 5 cd31 fitc cd34 apc - by Bioz Stars, 2026-07
    98/100 stars
    		  Buy from Supplier
    percp cy5 5 conjuated anti cd34  (Revvity)
    98
    Revvity percp cy5 5 conjuated anti cd34
    Percp Cy5 5 Conjuated Anti Cd34, supplied by Revvity, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+percp+cy5+5/pmc09887089-48-22-24?v=Revvity
    Average 98 stars, based on 1 article reviews
    percp cy5 5 conjuated anti cd34 - by Bioz Stars, 2026-07
    98/100 stars
    		  Buy from Supplier
    cd34 percp cy5 5  (Revvity)
    98
    Revvity cd34 percp cy5 5
    Cd34 Percp Cy5 5, supplied by Revvity, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+percp+cy5+5/pmc09981215-58-24-26?v=Revvity
    Average 98 stars, based on 1 article reviews
    cd34 percp cy5 5 - by Bioz Stars, 2026-07
    98/100 stars
    		  Buy from Supplier
    anti cd34 percp cy5 5 conjugate  (Agilent technologies)
    95
    Agilent technologies anti cd34 percp cy5 5 conjugate
    Anti Cd34 Percp Cy5 5 Conjugate, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+percp+cy5+5/us11047850-346-1-30?v=Agilent+technologies
    Average 95 stars, based on 1 article reviews
    anti cd34 percp cy5 5 conjugate - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    cd34 percp cy5 5  (Novus Biologicals)
    91
    Novus Biologicals cd34 percp cy5 5
    Cd34 Percp Cy5 5, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+percp+cy5+5/pmc08102597-209-22-23?v=Novus+Biologicals
    Average 91 stars, based on 1 article reviews
    cd34 percp cy5 5 - by Bioz Stars, 2026-07
    91/100 stars
    		  Buy from Supplier
    cd34 percp cy5 5  (Agilent technologies)
    95
    Agilent technologies cd34 percp cy5 5
    Cd34 Percp Cy5 5, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+percp+cy5+5/pm29096843-54-19-15?v=Agilent+technologies
    Average 95 stars, based on 1 article reviews
    cd34 percp cy5 5 - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    cd34 percp cy5 5  (Santa Cruz Biotechnology)
    95
    Santa Cruz Biotechnology cd34 percp cy5 5
    (A–D) Flow cytometric analysis of the populations of <t>CD34</t> + and CD34 + /VEGF-R2 + cells isolated from bone marrow (BM) and peripheral blood (PB). CNTX = non-dystrophic control rats without EPO treatment, CTX = non-dystrophic control rats receiving EPO treatment, DNTX = RCS rats without EPO treatment, DTX = RCS rats receiving EPO treatment. Box plots display the 25 th percentile, median (50 th percentile), 75 th percentile as well as the minimum and maximum number of cells analyzed. *P<0.01, EPO treated group vs not treated group; n = 7∼10/group.
    Cd34 Percp Cy5 5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+percp+cy5+5/pmc04132022-80-49-51?v=Santa+Cruz+Biotechnology
    Average 95 stars, based on 1 article reviews
    cd34 percp cy5 5 - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    (A–D) Flow cytometric analysis of the populations of CD34 + and CD34 + /VEGF-R2 + cells isolated from bone marrow (BM) and peripheral blood (PB). CNTX = non-dystrophic control rats without EPO treatment, CTX = non-dystrophic control rats receiving EPO treatment, DNTX = RCS rats without EPO treatment, DTX = RCS rats receiving EPO treatment. Box plots display the 25 th percentile, median (50 th percentile), 75 th percentile as well as the minimum and maximum number of cells analyzed. *P<0.01, EPO treated group vs not treated group; n = 7∼10/group.

    Journal: PLoS ONE

    Article Title: Systemic Administration of Erythropoietin Inhibits Retinopathy in RCS Rats

    doi: 10.1371/journal.pone.0104759

    Figure Lengend Snippet: (A–D) Flow cytometric analysis of the populations of CD34 + and CD34 + /VEGF-R2 + cells isolated from bone marrow (BM) and peripheral blood (PB). CNTX = non-dystrophic control rats without EPO treatment, CTX = non-dystrophic control rats receiving EPO treatment, DNTX = RCS rats without EPO treatment, DTX = RCS rats receiving EPO treatment. Box plots display the 25 th percentile, median (50 th percentile), 75 th percentile as well as the minimum and maximum number of cells analyzed. *P<0.01, EPO treated group vs not treated group; n = 7∼10/group.

    Article Snippet: In brief, cells were Fc-blocked (BD Biosciences, catalogue#550271) with 1 μg/million cells for 15 minutes on ice, and then stained with a designated antibody panel containing CD 45 PE.Cy5 (BD Biosciences, #559135), CD31 FITC (AbD Serotec, #MCA1334F), CD 146 PE (R&D Systems, #FAB3250P) CD90.1 APC (Miltenyi Biotech, #130-094-525) and CD34 PerCp.Cy5.5 (Santa Cruz, #sc-7324).

    Techniques: Isolation, Control

    (A–K) Immunostaining for CD34 + cells (red) on retinal wholemounts stained with isolectin B4 (IB4, green). (A–F, J) RCS rats treated with EPO. (G–I, K) RCS rats without EPO treatment. In the EPO treated retina, a large number of CD34 + cells with monocyte-like (larger arrows in C and F) and microglia-like (small arrows in F) morphology were detected in the superficial (A–F) rather than the deep (J) vascular plexuses. The arrowhead in (F) points to a CD34 + cell wrapping an injured vessel. Arrows in (I) point to degenerating (D) and severely narrowed (K) retinal capillaries in rats without EPO treatment. NT = age-matched RCS rats not treated with EPO. (L) Quantitative analysis of CD34 + cells on retinal wholemounts. * P<0.05, RCS rats treated with EPO vs RCS rats not treated group; n = 6/group. Scale bars: 100 µm in (A–C, G–K); 25 µm in (D–F).

    Journal: PLoS ONE

    Article Title: Systemic Administration of Erythropoietin Inhibits Retinopathy in RCS Rats

    doi: 10.1371/journal.pone.0104759

    Figure Lengend Snippet: (A–K) Immunostaining for CD34 + cells (red) on retinal wholemounts stained with isolectin B4 (IB4, green). (A–F, J) RCS rats treated with EPO. (G–I, K) RCS rats without EPO treatment. In the EPO treated retina, a large number of CD34 + cells with monocyte-like (larger arrows in C and F) and microglia-like (small arrows in F) morphology were detected in the superficial (A–F) rather than the deep (J) vascular plexuses. The arrowhead in (F) points to a CD34 + cell wrapping an injured vessel. Arrows in (I) point to degenerating (D) and severely narrowed (K) retinal capillaries in rats without EPO treatment. NT = age-matched RCS rats not treated with EPO. (L) Quantitative analysis of CD34 + cells on retinal wholemounts. * P<0.05, RCS rats treated with EPO vs RCS rats not treated group; n = 6/group. Scale bars: 100 µm in (A–C, G–K); 25 µm in (D–F).

    Article Snippet: In brief, cells were Fc-blocked (BD Biosciences, catalogue#550271) with 1 μg/million cells for 15 minutes on ice, and then stained with a designated antibody panel containing CD 45 PE.Cy5 (BD Biosciences, #559135), CD31 FITC (AbD Serotec, #MCA1334F), CD 146 PE (R&D Systems, #FAB3250P) CD90.1 APC (Miltenyi Biotech, #130-094-525) and CD34 PerCp.Cy5.5 (Santa Cruz, #sc-7324).

    Techniques: Immunostaining, Staining